Dibutylamine,
If you find any inaccurate information, please let us know by providing your feedback here
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C8H19N 129.24 CAS RN®: 111-92-2-Colorless liquid.
Assay: Inject an appropriate volume into a gas chromatograph (see Chromatography (621)) equipped with a flame-ionization detector, helium being used as the carrier gas. The following conditions have been found suitable: a 0.25-mm x 30-m capillary column coated with a 1-µm layer of phase G2; the injection port temperature is maintained at 200°; the detector temperature is maintained at 300°; and the column temperature is maintained at 100° and programmed to rise 10° per minute to 200°. The area of the C8H19N peak is not less than 99% of the total peak area.
REFRACTIVE INDEX (831); between 1.415 and 1.419 at 20°.
